Evidence map›Paper›PMID 38255853›Full record

ArticleInternational journal of molecular sciences2024

Mimicking Protein Kinase C Phosphorylation Inhibits Arc/Arg3.1 Palmitoylation and Its Interaction with Nucleic Acids.

Barbara Barylko, Clinton A Taylor, Jason Wang, Svetlana Earnest, Steve Stippec, Derk D Binns, Chad A Brautigam, David M Jameson, George N DeMartino, Melanie H Cobb and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Barbara BarylkoDepartment of Pharmacology, U.T. Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA.
Clinton A TaylorDepartment of Pharmacology, U.T. Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA.ORCID 0000-0002-8283-3393
Jason WangDepartment of Physiology, U.T. Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA.ORCID 0000-0002-4043-0131
Svetlana EarnestDepartment of Pharmacology, U.T. Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA.
Steve StippecDepartment of Pharmacology, U.T. Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA.
Derk D BinnsDepartment of Pharmacology, U.T. Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA.ORCID 0000-0003-4949-3507
Chad A BrautigamDepartment of Biophysics, U.T. Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA.
David M JamesonDepartment of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96844, USA.
George N DeMartinoDepartment of Physiology, U.T. Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA.
Melanie H CobbDepartment of Pharmacology, U.T. Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA.
Joseph P AlbanesiDepartment of Pharmacology, U.T. Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA.

Funding

UT Southwestern NORCP30DK127984 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jeffrey M Zigman · 2022 to 2026
$7.4M
PI31: a regulator of proteasome adaptation to stressR01GM129088 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI DEMARTINO, GEORGE N. · 2019 to 2022
$1.3M
Membrane Remodeling by Arc/Arg3.1R21MH119516 · NIMH · UNIVERSITY OF HAWAII AT MANOA · PI ALBANESI, JOSEPH P, JAMESON, DAVID MICHAEL · 2019 to 2020
$425k
NIDDK NIH HHS P30 DK127984NIGMS NIH HHS R01 GM129088NIH HHS GM129088NIH HHS MH119516NIMH NIH HHS R21 MH119516
6 · The paper itself

Abstract

Activity-regulated cytoskeleton-associated protein (Arc) plays essential roles in diverse forms of synaptic plasticity, including long-term potentiation (LTP), long-term depression (LTD), and homeostatic plasticity. In addition, it assembles into virus-like particles that may deliver mRNAs and/or other cargo between neurons and neighboring cells. Considering this broad range of activities, it is not surprising that Arc is subject to regulation by multiple types of post-translational modification, including phosphorylation, palmitoylation, SUMOylation, ubiquitylation, and acetylation. Here we explore the potential regulatory role of Arc phosphorylation by protein kinase C (PKC), which occurs on serines 84 and 90 within an α-helical segment in the N-terminal domain. To mimic the effect of PKC phosphorylation, we mutated the two serines to negatively charged glutamic acid. A consequence of introducing these phosphomimetic mutations is the almost complete inhibition of Arc palmitoylation, which occurs on nearby cysteines and contributes to synaptic weakening. The mutations also inhibit the binding of nucleic acids and destabilize high-order Arc oligomers. Thus, PKC phosphorylation of Arc may limit the full expression of LTD and may suppress the interneuronal transport of mRNAs.

Indexed as

LipoylationNucleic AcidsPhosphorylationProtein Kinase CProtein Processing, Post-TranslationalNucleic AcidsProtein Kinase CArc/Arg3.1neuronal activitynucleic acid bindingoligomerizationpalmitoylationphosphorylationpost-translational modificationsprotein kinase C

Identifiers

PMID38255853
PMCPMC10815921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.